Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 7/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Acetate SCHEMBL11027649 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Ethyl Acetate SCHEMBL29257732 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Ethyl Acetate SCHEMBL27622625 | 0.98 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Ethyl Acetate SCHEMBL2675053 | 0.98 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Ethyl Acetate SCHEMBL8340468 | 0.98 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Ethyl Acetate SCHEMBL27623309 | 0.98 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Hexane SCHEMBL5393958 | 0.98 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Hexane SCHEMBL5311101 | 0.96 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Ethyl Acetate SCHEMBL8361444 | 0.96 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Heptane SCHEMBL10663246 | 0.96 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 567 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117402203-A | Method for extracting and identifying hypolipidemic saponins in garlic residues | 临沂大学 | 2024-01-16 | — | — | CN | claimed |
| CN-115137092-B | Method for preparing tobacco extract by using low-temperature plasma-assisted ionic liquid | 江西中烟工业有限责任公司 | 2023-11-24 | — | — | CN | claimed |
| CN-114832022-B | Preparation of Phellinus linteus fruiting body phenol active substances and application thereof in regulating intestinal flora and uric acid metabolism | 湖北省农业科学院农产品加工与核农技术研究所 | 2023-09-15 | — | — | CN | claimed |
| CN-113514581-B | Quality control method of lung-heat clearing and toxin expelling granule | 中国中医科学院中医临床基础医学研究所 | 2023-08-08 | — | — | CN | claimed |
| CN-116514906-A | Preparation method of Cyclo (Pro-Glu-Phe) | 宜宾五粮液股份有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-112946129-B | Quality detection method of antidiarrheal syrup | 桂林三金药业股份有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-113820422-B | Fingerprint detection method for total glucosides of white paeony | 宁波立华制药有限公司 | 2023-05-23 | — | — | CN | claimed |
| WO-2023045005-A1 | METHOD FOR PREPARING TOTAL GLUCOSIDES OF PAEONIA | 宁波立华制药有限公司 | 2023-03-30 | — | — | WO | claimed |
| CN-115844958-A | Preparation method of total glucosides of paeony | 宁波立华制药有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-110882246-B | Extraction method and application of coptis alkaloid with different biological activities | 西南大学 | 2022-12-23 | — | — | CN | claimed |
| CN-1387888-A | Chinese medicine prepn for resisting osteoporosis | SHANGHAI INST PHARM INDUSTRY (CN) | 2003-01-01 | — | — | CN | claimed |
| US-20020051828-A1 | Mixtures which can be isolated from eugenia jambolana lamarck seeds, their preparation and the use of these mixtures and some of their constituents as medicaments | RHONE-POULENC RORER S.A. AND INSTITUT MALGACHE DE RECHERCHES APPLIQUEES | 2002-05-02 | — | — | US | claimed |
| CN-1080566-C | Mixtures obtainable by isolation from seeds of Eugenia jambolana, their preparation, and use of these mixtures and certain components thereof as medicaments | INST OF MALGACHE DE RECHARCHES (MG) | 2002-03-13 | — | — | CN | claimed |
| EP-0879058-B1 | MIXTURES DERIVED FROM GRAINS OF EUGENIA JAMBOLANA LAMARCK, PREPARATION AND USE OF SAID MIXTURES AND SOME OF THEIR CONSTITUENTS AS MEDICAMENTS | INST MALGACHE DE RECH S APPLIQ (MG) | 2001-06-06 | — | — | EP | claimed |
| US-5972342-A | ANTIDIABETIC AGENTS | RHONE-POULENC RORER S.A. (FR) | 1999-10-26 | — | — | US | claimed |
| CN-1210469-A | Mixtures obtainable by isolation from seeds of Eugenia jambolana, their preparation, and use of these mixtures and certain components thereof as medicaments | INST MALGACHE RECH APPL (MG) | 1999-03-10 | — | — | CN | claimed |
| CN-1194834-A | Method for extracting total glucoside of white peony root | ZHAO XINXIAN (CN) | 1998-10-07 | — | — | CN | claimed |
| EP-0453515-A4 | COMPOSITION AND METHOD FOR TREATMENT OF SENILE DEMENTIA | — | 1992-05-06 | — | — | EP | claimed |
| EP-0453515-A1 | COMPOSITION FOR TREATMENT OF SENILE DEMENTIA | PANG, Peter K. T. (CA) | 1991-10-30 | — | — | EP | claimed |
| WO-1990008315-A1 | COMPOSITION AND METHOD FOR TREATMENT OF SENILE DEMENTIA | PANG PETER K T (CA) | 1990-07-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020051828-A1 | Mixtures which can be isolated from eugenia jambolana lamarck seeds, their preparation and the use of these mixtures and some of their constituents as medicaments | CMPK1, LNPK, SYMPK | ALDH1A1 3373/4885LMNA 82/4885HSD17B10 2677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.